BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1613814)

  • 21. Adenosine, neurodegeneration and neuroprotection.
    Stone TW
    Neurol Res; 2005 Mar; 27(2):161-8. PubMed ID: 15829179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
    Von Lubitz DK; Lin RC; Bischofberger N; Beenhakker M; Boyd M; Lipartowska R; Jacobson KA
    Eur J Pharmacol; 1999 Mar; 369(3):313-7. PubMed ID: 10225368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective role of adenosine in cerebral ischaemia.
    Rudolphi KA; Schubert P; Parkinson FE; Fredholm BB
    Trends Pharmacol Sci; 1992 Dec; 13(12):439-45. PubMed ID: 1293870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
    Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine and the nervous system: pharmacological data and therapeutic perspectives.
    Guieu R; Dussol B; Halimi G; Bechis G; Sampieri F; Berland Y; Sampol J; Couraud F; Rochat H
    Gen Pharmacol; 1998 Oct; 31(4):553-61. PubMed ID: 9792214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
    von Lubitz DK
    Expert Opin Investig Drugs; 2001 Apr; 10(4):619-32. PubMed ID: 11281813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of adenosine in man; possible clinical implications.
    Sollevi A
    Prog Neurobiol; 1986; 27(4):319-49. PubMed ID: 3538187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosinergic approaches to stroke therapeutics.
    Marangos PJ
    Med Hypotheses; 1990 May; 32(1):45-9. PubMed ID: 1971912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurophysiological monitoring of the efficacy of the complex therapy of vascular and posttraumatic encephalopathy].
    Zhivolupov SA; Samartsev IN; Marchenko AA; Puljatkina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):25-9. PubMed ID: 23739436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential for new selective adenosine receptor ligands and metabolism inhibitors.
    Bowmer CJ; Yates MS
    Trends Pharmacol Sci; 1989 Sep; 10(9):339-41. PubMed ID: 2690422
    [No Abstract]   [Full Text] [Related]  

  • 31. The therapeutic window in ischemic brain injury.
    Pulsinelli WA
    Curr Opin Neurol; 1995 Feb; 8(1):3-5. PubMed ID: 7749513
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoprotective mechanisms in the CNS: some new lessons from white matter.
    Fern R; Ransom BR; Waxman SG
    Mol Chem Neuropathol; 1996 Feb; 27(2):107-29. PubMed ID: 8962597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
    Jacobson KA; van Galen PJ; Williams M
    J Med Chem; 1992 Feb; 35(3):407-22. PubMed ID: 1738138
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of critical care patients with substantial acute ischemic or traumatic brain injury.
    Strong AJ; Boutelle MG; Vespa PM; Bullock MR; Bhatia R; Hashemi P
    Crit Care Med; 2005 Sep; 33(9):2147-9; author reply 2149. PubMed ID: 16148510
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adenosine receptor ligands--drugs of the future?].
    Müller CE; Folkers G
    Pharm Unserer Zeit; 1989 May; 18(3):65-75. PubMed ID: 2657803
    [No Abstract]   [Full Text] [Related]  

  • 36. Adenosine agonists and global cerebral ischaemia.
    Kolvenbach R; Figge C; Godehardt E; Sandmann W
    Br J Clin Pharmacol; 1993 Aug; 36(2):134-5. PubMed ID: 8398583
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenosine and adenosine receptors in immune function. Minireview and meeting report.
    Gilbertsen RB
    Agents Actions; 1987 Oct; 22(1-2):91-8. PubMed ID: 3318325
    [No Abstract]   [Full Text] [Related]  

  • 38. Dynamic and Rapid Detection of Guanosine during Ischemia.
    Weese-Myers ME; Cryan MT; Witt CE; Caldwell KCN; Modi B; Ross AE
    ACS Chem Neurosci; 2023 May; 14(9):1646-1658. PubMed ID: 37040534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebroprotection--catchword or therapeutic concept?].
    Krier C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 May; 26(3):123-5. PubMed ID: 1873420
    [No Abstract]   [Full Text] [Related]  

  • 40. Subtypes of adenosine receptors.
    Ribeiro JA; Sebastião AM
    Trends Pharmacol Sci; 1988 Aug; 9(8):279-80. PubMed ID: 3250052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.